Status:

COMPLETED

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Lead Sponsor:

Brigham and Women's Hospital

Collaborating Sponsors:

Icahn School of Medicine at Mount Sinai

Montefiore Medical Center

Conditions:

Coronavirus Infection

Eligibility:

All Genders

18+ years

Brief Summary

Multicenter observational/registry study of the clinical features and outcomes of critically ill patients with COVID-19.

Detailed Description

The goals of this project are to determine the independent risk factors for hospital mortality and acute organ injury, and to identify treatment strategies associated with improved survival. Additiona...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (each of the following):
  • Adults (aged ≥18 years)
  • Laboratory-confirmed diagnosis of COVID-19
  • Hospitalized in the ICU for illness related to COVID-19
  • Exclusion Criteria:
  • None

Exclusion

    Key Trial Info

    Start Date :

    April 1 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2023

    Estimated Enrollment :

    5154 Patients enrolled

    Trial Details

    Trial ID

    NCT04343898

    Start Date

    April 1 2020

    End Date

    July 1 2023

    Last Update

    August 9 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Brigham and Women's Hospital

    Boston, Massachusetts, United States, 02115

    Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 | DecenTrialz